stimulant use disorder. Other stimulant dependence
Conditions
Interventions
Intervention 1: Intervention group: cue exposure treatment. Intervention 2: Control group: treatment as usual (TAU).
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: stimulant use disorder diagnosis not using any kind of drug except of nicotine within two weeks before program starting Ability of reading and writing persian language Completion of informed consent form
Exclusion criteria
Exclusion criteria: having sever suicidal ideation having psychotic symptoms having acute physical problems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment outcome includes: addiction severity, craving, relapse rate, quality of life and severity of depression, anxiety and stress that will be measured by addiction severity index (ASI), Desires for Drug Questionnaire (DDQ), Obsessive Compulsive Drug Use Scale (OCDUS), urine test, World Health Organization Quality of Life-Brief (WHOQOL-BREF) and Depression Anxiety Stress Scales (DASS-21). Timepoint: assessment will complete at pre-test, post-test and follow up (3 months after treatment completion). Method of measurement: addiction severity index (ASI), Desires for Drug Questionnaire (DDQ), Obsessive Compulsive Drug Use Scale (OCDUS), urine test, World Health Organization Quality of Life-Brief (WHOQOL-BREF) and Depression Anxiety Stress Scales (DASS-21). | — |
Secondary
| Measure | Time frame |
|---|---|
| Addiction severity. Timepoint: pretest, post test, 3 months follow up. Method of measurement: addiction severity index (ASI).;Craving. Timepoint: pretest, post test, 3 months follow up. Method of measurement: Desires for Drug Questionnaire (DDQ) and Obsessive Compulsive Drug Use Scale (OCDUS).;Relapse rate. Timepoint: pretest, post test, 3 months follow up. Method of measurement: urine test.;Quality of life. Timepoint: pretest, post test, 3 months follow up. Method of measurement: World Health Organization Quality of Life-Brief (WHOQOL-BREF).;Severity of depression, anxiety and stress. Timepoint: pretest, post test, 3 months follow up. Method of measurement: Depression Anxiety Stress Scales (DASS-21). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMeghdad Talebizadeh
Iran University of Medical Sciences
Outcome results
None listed